Literature DB >> 28178252

Situating brain regions among patent rights and moral risks.

Dylan Roskams-Edris1, Stacey Anderson-Redick2, Zelma H Kiss3, Judy Illes1.   

Abstract

Mesh：

Year:  2017        PMID： 28178252     DOI： 10.1038/nbt.3782

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  11 in total

1.  Risk management. Science and the precautionary principle.

Authors:  K R Foster; P Vecchia; M H Repacholi
Journal:  Science       Date:  2000-05-12       Impact factor: 47.728

Review 2.  The moral tollbooth: a method that makes use of the patent system to address ethical concerns in biotechnology.

Authors:  E Richard Gold; Timothy A Caulfield
Journal:  Lancet       Date:  2002-06-29       Impact factor: 79.321

3.  The human brain project.

Authors:  Henry Markram
Journal:  Sci Am       Date:  2012-06       Impact factor: 2.142

Review 4.  Patentability of Stem Cells in the United States.

Authors:  Sarah E Fendrick; Donald L Zuhn
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

5.  The global stem cell patent landscape: implications for efficient technology transfer and commercial development.

Authors:  Karl Bergman; Gregory D Graff
Journal:  Nat Biotechnol       Date:  2007-04       Impact factor: 54.908

6.  Law, history and lessons in the CRISPR patent conflict.

Authors:  Jacob S Sherkow
Journal:  Nat Biotechnol       Date:  2015-03       Impact factor: 54.908

7.  Patent landscaping for life sciences innovation: toward consistent and transparent practices.

Authors:  Tania Bubela; E Richard Gold; Gregory D Graff; Daniel R Cahoy; Dianne Nicol; David Castle
Journal:  Nat Biotechnol       Date:  2013-03       Impact factor: 54.908

8.  Research priorities. The NIH BRAIN Initiative.

Authors:  Thomas R Insel; Story C Landis; Francis S Collins
Journal:  Science       Date:  2013-05-10       Impact factor: 47.728

9.  Myriad stands alone.

Authors:  Jacob S Sherkow; Christopher Scott
Journal:  Nat Biotechnol       Date:  2014-07       Impact factor: 54.908

10.  GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up.

Authors:  Christos Sidiropoulos; Peter A LeWitt; Vincent J J Odekerken; P Richard Schuurman; Rob M A de Bie
Journal:  Neurology       Date:  2016-08-16       Impact factor: 9.910
View more
  3 in total

1.  Brain modulation and patent law.

Authors:  Andreas Kuersten; Anna Wexler
Journal:  Nat Biotechnol       Date:  2019-01-03       Impact factor: 54.908

2.  Reply to: "Brain modulation and patent law".

Authors:  Judy Illes; Zelma Kiss; Dylan Roskams-Edris; Stacey Anderson-Redick
Journal:  Nat Biotechnol       Date:  2019-01-03       Impact factor: 54.908

3.  Opening the debate on deep brain stimulation for Alzheimer disease - a critical evaluation of rationale, shortcomings, and ethical justification.

Authors:  Merlin Bittlinger; Sabine Müller
Journal:  BMC Med Ethics       Date:  2018-06-11       Impact factor: 2.652
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.